DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Wolpin BM, Hezel AF, Abrams T et al.
Oral mTOR inhibitor everolimus in patients with gemcitabine-refractory metastatic pancreatic cancer.
J Clin Oncol 2009;
27: 193-198
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.